EU Panel Backs Damoctocog Alfa Pegol for Hemophilia A EU Panel Backs Damoctocog Alfa Pegol for Hemophilia A
The EMA's CHMP recommended damoctocog alfa pegol (Jivi, Bayer AG) for the treatment and prophylaxis of bleeding in patients aged 12 years and older who have been previously treated for hemophilia A.International Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 24, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news

Are You Tall? Better Watch Out For Varicose Veins
(CNN) — In what researchers are calling “the largest genetic study ever performed” on varicose vein disease, a Stanford University School of Medicine study found a person’s height to be a significant risk factor for developing varicose veins. “We not only found an association between height and varicose veins, but the genetic studies we did showed a causal link,” said cardiologist and study author Dr. Nicholas Leeper, an associate professor of surgery and cardiovascular medicine at Stanford. “That suggests that the genes and pathways that drive human height are also likely to be ca...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - September 24, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News Local TV Varicose Veins Source Type: news

LEADERS FREE II Supports Biolimus Stent for High-Risk Patients LEADERS FREE II Supports Biolimus Stent for High-Risk Patients
LEADERS FREE II shows that results from the European LEADERS FREE trial apply to patients on'both sides of the Atlantic'who have a high bleeding risk and need a coronary stent.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 23, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news

Alydia Tackles Postpartum Hemorrhage with Device
A small startup is developing a device aimed at treating and preventing maternal bleeding. Menlo Park, CA-based Alydia has raised $10 million in a series B round to help it get the technology past clinical trials and onto the market in the U.S. The technology works with the normal contractions of the uterus to rapidly stop bleeding. The concept of the device was developed in 2010 at the Cal Poly Center for Innovation and Entrepreneurship. “What is used now are drugs, which work too slowly or might not work,” Anne Morrissey, CEO of Alydia Health, told MD+DI. “They also ...
Source: MDDI - September 21, 2018 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news

Implementation and evaluation of a first-responder bleeding-control training program in a rural police department - Reed JR, Carman MJ, Titch FJ, Kotwal RS.
BACKGROUND: In the prehospital environment, nonmedical first responders are often the first to arrive on the scene of a traumatic event and must be prepared to provide initial care at the point of injury. In civilian communities, these nonmedical first res... (Source: SafetyLit)
Source: SafetyLit - September 21, 2018 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

High blood pressure symptoms: Bleeding from this part of the body is a warning sign
HIGH blood pressure symptoms are rarely noticeable, but if they do show it ’s important to recognise them so you can get treatment and slash the risk of serious health problems. One of the signs to watch out for is bleeding from a particular part of the body. (Source: Daily Express - Health)
Source: Daily Express - Health - September 21, 2018 Category: Consumer Health News Source Type: news

Alydia Health raises $10m in Series B
Alydia Health, formerly known as InPress Technologies, said today it closed a $10 million Series B financing round to help support its technology platform designed to prevent maternal morbidity and mortality caused by postpartum hemorrhage. The round was led by the Global Health Investment Fund and joined by Astia Angles and other existing investors. As part of the round, Global Health Investment Fund managing partner Dr. Curt LaBelle will join the company’s board of directors. “Alydia Health’s solution for postpartum hemorrhage offers tremendous potential for mothers and families around the world, starti...
Source: Mass Device - September 20, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Funding Roundup Women's Health alydiahealth Source Type: news

Passengers bleed from ears, noses after Indian flight loses cabin pressure
A Jet Airways flight has returned to Mumbai, India's financial capital, after dozens of passengers complained of ear pain and nose bleeding due to a loss in cabin pressure. (Source: CBC | Health)
Source: CBC | Health - September 20, 2018 Category: Consumer Health News Tags: News/World Source Type: news

For A New Device To Treat Maternal Bleeding, A Young Entrepreneur's Big Step Was Passing The Torch
This morning, Alydia Health, a tiny Menlo Park, Calif., startup co-founded by a 21-year-old woman, announced that it has secured $10 million in funding to test a medical device to prevent mothers from bleeding to death after childbirth. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 20, 2018 Category: Pharmaceuticals Authors: Matthew Herper, Forbes Staff Source Type: news

Evidence for stress-induced bleeding in a patient with von Willebrand factor deficiency - Subramanian K, Pravallika M, Menon V.
Literature reveals that psychological stress is related to hemostatic mechanisms and that excess stress can lead to prothrombotic events. Patients with chronic bleeding disorders report increased levels of subjective distress. The psychobiological link bet... (Source: SafetyLit)
Source: SafetyLit - September 20, 2018 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

No Clear Benefit for Rivaroxaban After Hospital Discharge
Incidence of major bleeding low with rivaroxaban, but clot risk not lower (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - September 20, 2018 Category: Cancer & Oncology Tags: Cardiology, Internal Medicine, Oncology, Pharmacy, Journal, Source Type: news

It ’s Time to Train and Equip EMS Personnel to Respond to Active Threats
Over the past decade we’ve focused a great deal on attention to educating and equipping our law enforcement officers with individual first aid kits (IFAKs). We’ve not only equipped our officers with at least one commercially produced tourniquet and hemostatic dressings, but also trained them to manage severe extremity and junctional bleeding. Although much of the focus has been on law enforcement embracing the self-aid buddy aid (SABA) philosophy, many agencies have overlooked providing the same equipment and training to our EMS and fire department first responders. One reason behind this oversight may be a fla...
Source: JEMS Administration and Leadership - September 19, 2018 Category: Emergency Medicine Authors: Mark E.A. Escott, MD, MPH, FACEP, NRP Tags: Training Columns Terrorism & Active Shooter Exclusive Articles Administration and Leadership Source Type: news

It ’s Time to Train and Equip EMS Personnel to Respond to Active Threats
Over the past decade we’ve focused a great deal on attention to educating and equipping our law enforcement officers with individual first aid kits (IFAKs). We’ve not only equipped our officers with at least one commercially produced tourniquet and hemostatic dressings, but also trained them to manage severe extremity and junctional bleeding. Although much of the focus has been on law enforcement embracing the self-aid buddy aid (SABA) philosophy, many agencies have overlooked providing the same equipment and training to our EMS and fire department first responders. One reason behind this oversight may be a fla...
Source: JEMS Special Topics - September 19, 2018 Category: Emergency Medicine Authors: Mark E.A. Escott, MD, MPH, FACEP, NRP Tags: Training Columns Terrorism & Active Shooter Exclusive Articles Administration and Leadership Source Type: news

Channel Medsystems sues Boston Scientific over spiked $275m buyout
Channel Medsystems sued Boston Scientific (NYSE:BSX) this week over a $275 million buyout that Boston allegedly spiked over a former Channel employee’s alleged scheme to embezzle nearly $3 million from the women’s health company. Emeryville, Calif.-based Channel Medsystems developed Cerene, a cryogen-based endometrial ablation system designed to treat heavy menstrual bleeding that won CE Mark approval in the European Union in June 2017. In the U.S., the treatment phase is complete in a 242-woman pivotal investigational device exemption trial. The company has raised at least $47.6 million in ...
Source: Mass Device - September 19, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Featured Legal News Mergers & Acquisitions Wall Street Beat Boston Scientific Channel Medsystems Source Type: news

More Cases of Severe Bleeding in Wisconsin Linked to Synthetic Cannabinoids
The Wisconsin Department of Health Services (DHS) has confirmed 16 additional cases ofsevere bleeding caused by the use of synthetic cannabinoids containing rat poison. That brings the total number of people affected in this outbreak to 80. The counties with confirmed cases include Dane, Milwaukee, Outagamie, Rock, and now Fond du Lac. These cases have ranged in age from 16 to over 50 years old. To date, there has been one death in Wisconsin...(see release) (Source: Wisconsin DHFS Press Releases)
Source: Wisconsin DHFS Press Releases - September 18, 2018 Category: Hospital Management Authors: millejcodn Source Type: news

Saranas demonstrates Early Bird in first endovascular cases
Saranas said today that the first clinical cases using its Early Bird endovascular bleed monitoring system were performed at Atlantic Health System’s Morristown Medical Center in Morristown, N.J. The Early Bird device includes a vascular access sheath with embedded sensors that are designed to detect and monitor bleeding from a blood vessel accidentally injured during endovascular procedures, such as TAVR, large-bore hemodynamic support device placement, or other complex cardiovascular interventions in which the femoral artery or vein is used to obtain vascular access. The technology was invented at the Tex...
Source: Mass Device - September 18, 2018 Category: Medical Devices Authors: Nancy Crotti Tags: Blog Cardiovascular Research & Development saranas Source Type: news

Navigating the World of Digital Health Products
A presentation at MD&M Minneapolis aims to help medical device manufacturers and newcomers alike overcome the challenges of designing digital devices. “Scale and cost and prevalence of consumer-oriented technology like Wi fi and Bluetooth and cell phones have made possible a whole new category of health-related devices,” Bill Betten, president of Betten Systems Solutions LLC, told MD+DI. He will discuss digital health products in a talk on November 1 at MD&M Minneapolis, “Case Study: Overcoming Digital Health Product Development.” T...
Source: MDDI - September 18, 2018 Category: Medical Devices Authors: Susan Shepard Tags: MD & M Minneapolis Digital Health Source Type: news

Should Healthy Seniors Take Aspirin Daily? New Study Raises Questions
In this study, 70 and older, no benefit at all and potentially some harm,” Agus said. “In age 50, there’s a clear benefit in people who have high risk for heart disease that’s greater than 10 percent chance, and there’s a benefit on cancer, particularly colon cancer, in that study. In age 60 and above, it’s really the decision of the doctor and the patient together.” According to Agus, the big takeaway from the study is to not start taking aspirin in your 70s if you aren’t already on it. “This is an important study and a well-done study and it means if you haven’t...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - September 17, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News aspirin Local TV Source Type: news

Taking Daily Aspirin May Be Risky for Healthy Older Adults: Study
For years, taking a daily aspirin was believed to be one of the easiest ways to protect long-term health. But the bottom line on aspirin has recently gotten more complicated. Some research finds that aspirin can potentially reduce the risk of heart attacks and cancer, and some suggests that aspirin’s possible side effects, such as bleeding and ulcers, overshadow its advantages for many people. Now, a trio of new research articles are calling that classic health advice further into question. The research, published in the New England Journal of Medicine, suggests that taking a daily aspirin offers few appreciable heal...
Source: TIME: Health - September 17, 2018 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized Drugs healthytime Source Type: news

Does daily aspirin therapy work?
New research raises questions about aspirin therapy where people take daily low doses of the drug. Three reports in the New England Journal of Medicine found that among healthy senior citizens, the death rate for those taking aspirin was higher than for those who did not. The study also found an increased risk of certain types of internal bleeding among those who take the drug and no cardiac benefit. Dr. David Agus joins "CBS This Morning" to discuss the findings. (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - September 17, 2018 Category: Consumer Health News Source Type: news

Aspirin doesn't lower heart attack and stroke risks and can increase bleeding
Researchers found that a daily dose of aspirin didn't prolong healthy, independent living free of dementia. (Source: the Mail online | Health)
Source: the Mail online | Health - September 17, 2018 Category: Consumer Health News Source Type: news

ASPREE: Aspirin Bombs Again for Primary Prevention
(MedPage Today) -- All-cause and cancer-related mortality higher with aspirin; so were bleeding events (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - September 16, 2018 Category: Cardiology Source Type: news

Penis cancer symptoms: Bleeding from this area of the penis could indicate the disease
PENILE cancer symptoms can be similar to those of other less serious medical conditions, but if you suspect you have any of the signs it ’s important to see your GP. One indicator of the disease to look out for is bleeding from the penis. (Source: Daily Express - Health)
Source: Daily Express - Health - September 13, 2018 Category: Consumer Health News Source Type: news

Penile cancer symptoms: Bleeding from this area of the penis could indicate the disease
PENILE cancer symptoms can be similar to those of other less serious medical conditions, but if you suspect you have any of the signs it ’s important to see your GP. One of the signs to look out for is bleeding. (Source: Daily Express - Health)
Source: Daily Express - Health - September 13, 2018 Category: Consumer Health News Source Type: news

Boy Survives After Meat Skewer Pierces Skull
HARRISONVILLE, Mo. (AP) — A 10-year-old Missouri boy is recovering after he was attacked by insects and tumbled from a tree, landing on a meat skewer that penetrated his skull from his face to the back of his head. But miraculously, that's where Xavier Cunningham's bad luck ended. The skewer had completely missed Xavier's eye, brain, spinal cord and major blood vessels, The Kansas City Star reports . Xavier's harrowing experience began Saturday afternoon when yellow jackets attacked him in a tree house at his home in Harrisonville, about 35 miles (56 kilometers) south of Kansas City. He fell to the ground and started...
Source: JEMS Patient Care - September 12, 2018 Category: Emergency Medicine Authors: Associated Press Tags: Trauma News Source Type: news

Boy Survives After Meat Skewer Pierces Skull
HARRISONVILLE, Mo. (AP) — A 10-year-old Missouri boy is recovering after he was attacked by insects and tumbled from a tree, landing on a meat skewer that penetrated his skull from his face to the back of his head. But miraculously, that's where Xavier Cunningham's bad luck ended. The skewer had completely missed Xavier's eye, brain, spinal cord and major blood vessels, The Kansas City Star reports . Xavier's harrowing experience began Saturday afternoon when yellow jackets attacked him in a tree house at his home in Harrisonville, about 35 miles (56 kilometers) south of Kansas City. He fell to the ground and started...
Source: JEMS: Journal of Emergency Medical Services News - September 12, 2018 Category: Emergency Medicine Authors: Associated Press Tags: Trauma News Source Type: news

New Ebola outbreak hits women and girls hardest in the Democratic Republic of the Congo
MANGINA, Democratic Republic of the Congo – On 1 August, just one week after the World Health Organization declared an end to the ninth Ebola outbreak in the Democratic Republic of the Congo, the tenth struck.  “We had two sick people in the centre – a man and a youth – who died of unknown causes,” recalled Sister Yvette Kanyere, manager of the Mangina Reference Health Centre. “They were bleeding everywhere and we did not know what had happened [to them].” (Source: UNFPA News)
Source: UNFPA News - September 10, 2018 Category: International Medicine & Public Health Authors: ashton Source Type: news

Medtronic launches one-month DAPT study for drug-eluting stent in U.S., Japan
Medtronic (NYSE:MDT) said today that it’s launching a study in the U.S. and Japan to evaluate dual antiplatelet therapy in high bleeding risk patients implanted with the Resolute Onyx drug-eluting stent during percutaneous coronary intervention. The company’s Onyx One Clear study is one of the first designed to assess the risk of cardiac death and stent thrombosis following DAPT interruption or discontinuation after one month with a next-gen drug-eluting stent, according to Medtronic. Get the full story at our sister site, Drug Delivery Business News. The post Medtronic launches one-month DAPT study for dr...
Source: Mass Device - September 10, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Cardiovascular Clinical Trials Drug-Device Combinations Drug-Eluting Stents Pharmaceuticals Wall Street Beat Medtronic Source Type: news

Blood cancer symptoms: Bleeding from this area of the body is a sign of the deadly disease
BLOOD cancer symptoms can be mistaken for less serious health conditions, but it ’s important to recognise all the signs to avoid potentially fatal consequences and complications. One indicator of the disease is bleeding from certain areas of the body. (Source: Daily Express - Health)
Source: Daily Express - Health - September 5, 2018 Category: Consumer Health News Source Type: news

High blood pressure symptoms: Bleeding from this part of the body can signal hypertension
HIGH BLOOD pressure doesn ’t usually have any symptoms, but there is one common problem people often get at some stage in their lives which could actually be a sign of the condition. (Source: Daily Express - Health)
Source: Daily Express - Health - September 3, 2018 Category: Consumer Health News Source Type: news

Global Access to Quality, Affordable Care
August 31, 2018This year's  Extreme Affordability Conference in Ghana had something new to offer.Something special happens when stage and subject align. Earlier this summer, after trading air-conditioned ballrooms for steamy tents in sub-Saharan Africa, the Extreme Affordability Conference achieved that alignment. Although the conference has always been about improving access to global health resources, taking the event to Ghana maximized global partnerships in new ways.Leveraging Combined Strengths and ConnectionsThe University of Utah ’s Division of Public Health has been working in Africa for nearly two decad...
Source: IntraHealth International - August 31, 2018 Category: International Medicine & Public Health Authors: mnathe Source Type: news

Eight More Cases of Severe Bleeding and Hospitalizations Due to “Fake Weed” in Wisconsin
Wisconsin continues to see cases of severe bleeding following the use of synthetic cannabinoids, often called “fake weed,” “K2,” and “spice.” The bleeding occurs asthese products contain rat poison (brodifacoum). Overall, Wisconsin has seen 54 cases since March of this year, with 40 confirmed and 14 probable. Counties with confirmed cases include Dane, Milwaukee, Outagamie, and Rock. “There have been eight new cases in the last two weeks,”...(see release) (Source: Wisconsin DHFS Press Releases)
Source: Wisconsin DHFS Press Releases - August 31, 2018 Category: Hospital Management Authors: goodsesjfs Source Type: news

India's oxytocin ban delayed by a month as Delhi HC hears cases against it
Oxytocin is a hormone drug used to induce labour in pregnant women and stall post-partum bleeding. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 31, 2018 Category: Pharmaceuticals Source Type: news

Postmenopausal Bleeding Common in Women With Endometrial Cancer
A meta-analysis finds that postmenopausal bleeding occurs in approximately 90% of women with endometrial cancer. (Source: CancerNetwork)
Source: CancerNetwork - August 30, 2018 Category: Cancer & Oncology Authors: Leah Lawrence Source Type: news

FDA Clears New Hemophilia A Drug With Flexible Dosing FDA Clears New Hemophilia A Drug With Flexible Dosing
Jivi (antihemophilic factor [recombinant] PEGylated-aucl) is for routine prophylactic treatment, on-demand treatment, and perioperative management of bleeding in adults and in adolescents 12 and older.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 30, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news

Emicizumab Prophylaxis Cuts Bleeding in Hemophilia A
WEDNESDAY, Aug. 29, 2018 -- For patients with hemophilia A without factor VIII inhibitors, emicizumab prophylaxis leads to a significantly reduced bleeding rate, according to a study published in the Aug. 30 issue of the New England Journal of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 29, 2018 Category: Pharmaceuticals Source Type: news

ESC: Early Bleeding on Antithrombotics May Signal Ca
(MedPage Today) -- Strong association between GI/GU bleeding, GI/GU cancer (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - August 28, 2018 Category: Gastroenterology Source Type: news

Early Bleeding on Antithrombotics May Signal Ca
(MedPage Today) -- Strong association between GI/GU bleeding, GI/GU cancer (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - August 28, 2018 Category: Cardiology Source Type: news

Heart benefits of fish oil, aspirin questioned in diabetics
(Reuters Health) - A new large study of fish oil and aspirin in people with diabetes has found that the oil supplements don't prevent first-time heart attacks or strokes, yet aspirin does, although the benefit of aspirin therapy is canceled out by a higher risk of unwanted bleeding. (Source: Reuters: Health)
Source: Reuters: Health - August 28, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

The missing ingredient to a health system ’s patient experience
The healthcare landscape is facing powerful and disruptive market forces that are rapidly dismantling norms and traditional business operations. These trends are no secret to the industry here in Minnesota. Consumers want more control of their care and increased transparency around costs, while health systems and payers are in a race to lower them. Consumer experiences in other industries are bleeding into healthcare, bringing new demands for a simpler, more digital experience. Amid all that, the… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - August 28, 2018 Category: American Health Authors: Chris Althoff and Andrew Walker Source Type: news

Aspirin, Fish Oil May Not Help With Heart Risk
Meanwhile, a second set of studies discovered the news was just as grim for those with diabetes, as a higher risk for serious bleeding canceled out a modest benefit. (Source: WebMD Health)
Source: WebMD Health - August 27, 2018 Category: Consumer Health News Source Type: news

ASCEND: Aspirin Not Needed for Primary Prevention in Diabetes ASCEND: Aspirin Not Needed for Primary Prevention in Diabetes
The benefit of aspirin on reducing vascular events did not outweigh the increased risk for serious bleeding in this new large primary prevention trial in diabetic patients.Medscape Medical News (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - August 27, 2018 Category: Surgery Tags: Cardiology News Source Type: news

Studies: Low-Dose Aspirin May Not Prevent Initial Heart Attack, Stroke
Taking a low-dose aspirin every day has long been known to cut the chances of another heart attack, stroke or other heart problem in people who already have had one, but the risks don’t outweigh the benefits for most other folks, major new research finds. Although it’s been used for more than a century, aspirin’s value in many situations is still unclear. The latest studies are some of the largest and longest to test this pennies-a-day blood thinner in people who don’t yet have heart disease or a blood vessel-related problem. One found that aspirin did not help prevent first strokes or heart attacks...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - August 27, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Healthwatch aspirin Source Type: news

Here & #039;s What MD+DI Readers Said About The Bleeding Edge
As part of MD+DI's coverage last week of the Netflix documentary, The Bleeding Edge, we asked readers for feedback on the film and its assessment of the medical device industry. A total of 62 respondents took the three-question survey.  1. The Bleeding Edge claims that FDA's 510(k) process, reportedly the most popular way medical devices reach the U.S. market, doesn’t require the submission of as much safety data as does the premarket approval (PMA) process. Do you believe this is a fair depiction? Of the 62 respondents who answered this question, 48 (77.42%) said yes, and just 14 ...
Source: MDDI - August 27, 2018 Category: Medical Devices Authors: MDDI Staff Tags: Regulatory and Compliance Source Type: news

No Reduction in VTE, Death With Rivaroxaban Post-Discharge No Reduction in VTE, Death With Rivaroxaban Post-Discharge
MARINER trial results showed no benefit in reducing a composite of symptomatic venous thromboembolism and death after discharge in high-risk hospitalized patients, although bleeding risk was also low.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 26, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news

Cancer may lurk behind major internal bleeding in cardiovascular disease patients
(McMaster University) Patients with cardiovascular disease who develop major internal bleeding are much more likely to be diagnosed with cancer, a large international clinical trial has found.Patients with gastrointestinal (GI) bleeding are 18 times more likely to be diagnosed with GI tract cancer, and those who major genitourinary (GU) tract bleeding are 80-fold more likely to be diagnosed with GU cancer, than patients without internal GI or GU bleeding, respectively.The study results were presented today at the European Society of Cardiology Congress (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 26, 2018 Category: Cancer & Oncology Source Type: news

Netflix ’ s ‘ The Bleeding Edge ’ raises big questions for medical device manufacturers
Sandra Maddock, president and CEO, IMARC Research Thanks in large part to innovation in the medical device industry, the average human lifespan has nearly doubled in the past hundred years. Medical devices have undoubtedly improved the quality of life for millions of people, too. But a provocative new Netflix documentary raises an important question: Is there a point when innovation goes too far? The Bleeding Edge, produced by Academy-Award nominated filmmakers Kirby Dick and Amy Ziering, tells the stories of patients who say they’ve suffered serious health problems as a result of recent medical devices being used ...
Source: Mass Device - August 24, 2018 Category: Medical Devices Authors: Danielle Kirsh Tags: Blog IMARC Source Type: news

Routine Tranexamic Acid Therapy Fails to Prevent Postpartum Hemorrhage Routine Tranexamic Acid Therapy Fails to Prevent Postpartum Hemorrhage
Tranexamic acid, given to women with postpartum hemorrhage, can save them from bleeding to death. But a new report says routine administration of the drug immediately after delivery does not itself reduce the risk of postpartum hemorrhage.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 24, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

FDA says ‘no go’ to an Allergan women’s health med
The FDA has declined to approve a medication developed by Allergan to treat abnormal bleeding in women with uterine fibroids. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - August 22, 2018 Category: Pharmaceuticals Source Type: news